Hypothesis

3 Matching Annotations

Aug 2024
www.mdpi.com www.mdpi.com

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth

1
1. scibot 02 Aug 2024
  
  in Public
  
  K-HOS
  
  DOI: 10.3390/cancers12123847
  
  Resource: (RRID:CVCL_2546)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_2546
  
  What is this?
  
  RRID:CVCL_2546 RRIDCUR:Missing
Visit annotations in context

Tags

RRID:CVCL_2546

RRIDCUR:Missing

Annotators

scibot

URL

mdpi.com/2072-6694/12/12/3847/htm
Jul 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma

1
1. scibot 06 Jul 2023
  
  in Public
  
  RRID : CVCL_2546
  
  DOI: 10.3389/fonc.2023.1192472
  
  Resource: (RRID:CVCL_2546)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_2546
  
  What is this?
  
  RRID:CVCL_2546
Visit annotations in context

Tags

RRID:CVCL_2546

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC10315670/
Jan 2023
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Targeting Podoplanin for the Treatment of Osteosarcoma

1
1. scibot 12 Jan 2023
  
  in Public
  
  CVCL_2546
  
  DOI: 10.1158/1078-0432.CCR-21-4509
  
  Resource: (RRID:CVCL_2546)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2546
  
  What is this?
  
  RRID:CVCL_2546
Visit annotations in context

Tags

RRID:CVCL_2546

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC9359727/